121 related articles for article (PubMed ID: 8625365)
1. Effects of N(g)-methyl-L-arginine, an inhibitor of nitric oxide synthesis, on interleukin-2-induced capillary leakage and antitumor responses in healthy and tumor-bearing mice.
Orucevic A; Lala PK
Cancer Immunol Immunother; 1996 Jan; 42(1):38-46. PubMed ID: 8625365
[TBL] [Abstract][Full Text] [Related]
2. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin 2-induced capillary leakage and reduces tumour growth in adenocarcinoma-bearing mice.
Orucevic A; Lala PK
Br J Cancer; 1996 Jan; 73(2):189-96. PubMed ID: 8546905
[TBL] [Abstract][Full Text] [Related]
3. NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, ameliorates interleukin-2-induced capillary leak syndrome in healthy mice.
Orucevic A; Lala PK
J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):210-20. PubMed ID: 8680649
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of C3H/HeJ mammary adenocarcinoma with interleukin-2, mistletoe lectin or their combination. effects on tumour growth, capillary leakage and nitric oxide (NO) production.
Timoshenko AV; Lan Y; Gabius HJ; Lala PK
Eur J Cancer; 2001 Oct; 37(15):1910-20. PubMed ID: 11576848
[TBL] [Abstract][Full Text] [Related]
5. The role of active inducible nitric oxide synthase expression in the pathogenesis of capillary leak syndrome resulting from interleukin-2 therapy in mice.
Orucevic A; Hearn S; Lala PK
Lab Invest; 1997 Jan; 76(1):53-65. PubMed ID: 9010449
[TBL] [Abstract][Full Text] [Related]
6. Effects of N(G)-Nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, on IL-2-induced LAK cell generation in vivo and in vitro in healthy and tumor-bearing mice.
Orucevic A; Lala PK
Cell Immunol; 1996 Apr; 169(1):125-32. PubMed ID: 8612285
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 1 alpha and gamma-interferon induction of nitric oxide production from murine tumor-derived endothelial cells.
Chang MJ; Modzelewski RA; Russell DM; Johnson CS
Cancer Res; 1996 Feb; 56(4):886-91. PubMed ID: 8631029
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo.
Edwards P; Cendan JC; Topping DB; Moldawer LL; MacKay S; Copeland EMIII ; Lind DS
J Surg Res; 1996 Jun; 63(1):49-52. PubMed ID: 8661171
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and toxicity of protracted nitric oxide synthesis inhibition during IL-2 treatment of mice.
Samlowski WE; Yim CY; McGregor JR; Kwon OD; Gonzales S; Hibbs JB
J Immunother Emphasis Tumor Immunol; 1995 Oct; 18(3):166-78. PubMed ID: 8770772
[TBL] [Abstract][Full Text] [Related]
10. Effects of nitric oxide (NO) synthesis inhibition on antitumor responses during interleukin-2 (IL-2) treatment of mice.
Yim CY; Lee CW; Choi SM; Park SS; Lee SJ; Kim JH; Song JS; Yoo WH; Kwak JY; Sohn MH
Korean J Intern Med; 1996 Jun; 11(2):93-100. PubMed ID: 8854644
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma.
Meyer RE; Shan S; DeAngelo J; Dodge RK; Bonaventura J; Ong ET; Dewhirst MW
Br J Cancer; 1995 Jun; 71(6):1169-74. PubMed ID: 7540036
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nitric oxide synthesis does not improve interleukin-2-mediated antitumor effects in vivo.
Leder GH; Oppenheim M; Rosenstein M; Shah N; Hoffman R; Lotze MT; Beger HG
Eur Surg Res; 1996; 28(3):167-78. PubMed ID: 8738527
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis.
Jadeski LC; Hum KO; Chakraborty C; Lala PK
Int J Cancer; 2000 Apr; 86(1):30-9. PubMed ID: 10728591
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous nitric oxide in airway microvascular leakage induced by inflammatory mediators.
Kageyama N; Miura M; Ichinose M; Tomaki M; Ishikawa J; Ohuchi Y; Endoh N; Shirato K
Eur Respir J; 1997 Jan; 10(1):13-9. PubMed ID: 9032485
[TBL] [Abstract][Full Text] [Related]
15. NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs.
Kilbourn RG; Owen-Schaub LB; Cromeens DM; Gross SS; Flaherty MJ; Santee SM; Alak AM; Griffith OW
J Appl Physiol (1985); 1994 Mar; 76(3):1130-7. PubMed ID: 8005855
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of mammary adenocarcinoma metastases in C3H/HeN mice with chronic administration of cyclo-oxygenase inhibitors alone or in combination with IL-2.
Khoo NK; Chan FP; Saarloos MN; Lala PK
Clin Exp Metastasis; 1992 Jul; 10(4):239-52. PubMed ID: 1617832
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase.
Jadeski LC; Chakraborty C; Lala PK
Int J Cancer; 2003 Sep; 106(4):496-504. PubMed ID: 12845643
[TBL] [Abstract][Full Text] [Related]
18. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension.
Kilbourn RG; Fonseca GA; Griffith OW; Ewer M; Price K; Striegel A; Jones E; Logothetis CJ
Crit Care Med; 1995 Jun; 23(6):1018-24. PubMed ID: 7774211
[TBL] [Abstract][Full Text] [Related]
19. Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness.
Orucevic A; Bechberger J; Green AM; Shapiro RA; Billiar TR; Lala PK
Int J Cancer; 1999 Jun; 81(6):889-96. PubMed ID: 10362135
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
